Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study
- 29 July 2006
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 166 (1) , 13-21
- https://doi.org/10.1007/s00431-006-0193-1
Abstract
Objective: The aim of this study was to assess the changes in body fat distribution and lipid abnormalities in a population of HIV-infected children and adolescents followed in one single centre who had been exposed, or not, to antiretroviral therapy (ART). Materials and methods: Patients aged between 3 and 19 years were evaluated in a cross-sectional study carried out between October and December 2002. Fat redistribution was evaluated independently by the physician and the patient. Fasting blood lipid profile, glucose, insulin and C peptide were measured. Among the 88 patients evaluated, 74 were taking ART. Results: Fat redistribution was present in 20 patients, metabolic alterations alone were found in 22 children and 46 children had neither physical nor metabolic abnormalities. Patients with fat redistribution were found to have been on ART for a significantly longer period of time, with 42% of the children showing fat redistribution having been treated with anitretroviral agents for more than 5 years. These children had also been exposed to a higher number of antiretroviral agents. In contrast, metabolic alterations in the absence of fat redistribution were not related to the duration of ART nor to the number of drugs received. Treatment with stavudine or protease inhibitors was significantly associated with the presence of physical changes. Conclusion: Regular assessment of fat redistribution and metabolic markers should be carried out in children treated with antiretroviral agents and taken into account when adapting therapy during the long-term follow up of these children. © 2006 Springer-Verlag.SCOPUS: ar.jinfo:eu-repo/semantics/publisheKeywords
This publication has 40 references indexed in Scilit:
- Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral TherapyPLoS Medicine, 2006
- Early Structural and Functional Changes of the Vasculature in HIV-Infected ChildrenCirculation, 2005
- Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected childrenEuropean Journal of Pediatrics, 2005
- Cardio- and cerebrovascular events in HIV-infected personsAIDS, 2004
- Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in EuropeAIDS, 2004
- Severe insulin resistance contrasting with mild anthropometric changes in the adipose tissue of HIV-infected children with lipohypertrophyInternational Journal of Obesity, 2003
- Increased risk of lipoatrophy under stavudine in HIV-1-infected patientsAIDS, 2002
- Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone releaseInternational Journal of Obesity, 2002
- Risk factors for the HIV‐associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatmentHIV Medicine, 2002
- Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999Clinical Infectious Diseases, 2000